FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, in particular to a method for increasing the stability of α/β-hydrolase. α/β-hydrolases having a reduced total mean value of hydropathy (GRAVY) have also been proposed. In addition, the present invention relates to the use of α/β-hydrolase for the degradation of zearalenone (ZEN).
EFFECT: invention makes it possible to increase the efficiency of the degradation of zearalenone.
17 cl, 9 dwg, 2 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIOMARKER | 2019 |
|
RU2808079C2 |
| IMMUNOGLOBULINS BINDING AGGRECAN | 2018 |
|
RU2771818C2 |
| NEW LIVER TARGETING ADENO-ASSOCIATED VIRAL VECTORS | 2019 |
|
RU2793735C2 |
| NEW VERSION OF HYDROLASE AND A METHOD FOR OBTAINING L-TRYPTOPHAN | 2021 |
|
RU2793185C1 |
| IMPROVED SYNTHETIC T-CELL RECEPTOR AND ANTIGEN RECEPTOR | 2021 |
|
RU2820497C1 |
| NOVEL SPECIFIC BINDING POLYPEPTIDES AND ROUTES OF USE THEREOF | 2015 |
|
RU2723034C2 |
| POLYPEPTIDES BINDING TO ADAMTS5, MMP13, AND AGGRECAN | 2018 |
|
RU2786659C2 |
| VARIANTS OF ACID ALPHA-GLUCOSIDASE AND THEIR USE | 2017 |
|
RU2780410C2 |
| STRUCTURES HAVING SIRP-ALPHA DOMAIN OR ITS VERSION | 2016 |
|
RU2740672C2 |
| RECOMBINANT VIRAL PARTICLES WITH MODIFIED TROPISM AND WAYS OF THEIR USE FOR TARGETED INTRODUCTION OF GENETIC MATERIAL INTO HUMAN CELLS | 2018 |
|
RU2811426C2 |
